Category Archives: Ovarian Cancer

Can aspirin prevent ovarian cancer?

ovarian-cancer-in-the-news

You may have read in recent news that a new research study found that daily, low-dose aspirin may lower a woman’s risk of developing ovarian cancer. So does that mean you should start — or change — your aspirin regimen? Dr. Nora Disis, our Medical and Scientific Director and the Director of the University of […]

Hereditary Breast & Ovarian Cancer: What you need to know

hereditary-breast-ovarian-cancer

What is hereditary breast and ovarian cancer? 10-15% of ovarian cancer and 5-10% of breast cancer are hereditary. To kick off October as Breast Cancer Awareness Month, we’re going to dive into a lesser-discussed topic that bridges the gap between ovarian and breast cancer: hereditary breast and ovarian cancer (HBOC). Many people have a general […]

How to Reduce Your Risk for Breast and Ovarian Cancer

reduce-ovarian-cancer-risk

In addition to genetics and family history, environment plays a role in breast and ovarian cancer risk. Here are 5 lifestyle behaviors that have been scientifically shown to reduce your risk of ovarian and breast cancer: Be Physically Active — at least 30 minutes per day, 5 days per week Exercise has numerous health benefits, […]

Top 7 Myths About Ovarian and Breast Cancer

breast-and-ovarian-cancer-myths

Our CanCan parties are a fun, frank way to educate women on ovarian and breast cancer risks and symptoms. They also serve as an opportunity to bust those pesky cancer myths that continue to circulate (but have little or no scientific backing). Curious what questions we get asked the most at CanCan parties? Top Seven Ovarian and […]

Promising news for ovarian cancer treatment with another FDA approval for PARP inhibitors

ovarian-cancer-in-the-news

PARP inhibitors represent an important new class of anticancer agents that are having a major impact on ovarian cancer treatment. These drugs target vulnerabilities in DNA damage response and repair pathways especially in cancer cells that have defects in BRCA and related genes. In an important clinical development announced April 6, 2018, the FDA expanded […]

X